Original Post The U.S. Food and Drug Administration is warning consumers that the agency continues to receive adverse event reports related to selective androgen receptor modulators, commonly called SARMs. Social media posts by influencers and sellers of SARMs contribute to the availability and promotion of these dangerous products. Targeting teenagers and young adults, videos on…
Read MoreOriginal Post For Immediate Release: April 18, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for…
Read MoreOriginal Post For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in…
Read MoreOriginal Post Tick-borne diseases, such as Lyme disease, are on the rise in people and dogs. Reported cases in people in the U.S. increased from about 12,000 annually in 1995 to approximately 35,000 in 2019, according to the Centers for Disease Control and Prevention. However, not all diagnosed cases are reported and the CDC believes the…
Read MoreOriginal Post Agency Continues to Take Steps to Reduce New Cases of Opioid Use Disorder For Immediate Release: April 03, 2023 Today, the U.S. Food and Drug Administration announced it is requiring manufacturers of opioid analgesics dispensed in outpatient settings to make prepaid mail-back envelopes available to outpatient pharmacies and other dispensers as an additional…
Read MoreAgency Continues to Take Critical Steps to Reduce Drug Overdose Deaths Being Driven Primarily by Illicit Opioids Original Post For Immediate Release: March 29, 2023 Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without…
Read MoreOriginal Post Summary Company Announcement Date: March 27, 2023 FDA Publish Date: March 28, 2023 Product Type: Drugs Reason for Announcement: Due to Presence of Methanol Company Name: Jarman’s Midwest Cleaning Systems, Inc. Brand Name: Midwest Cleaning Solutions, Clean Pro Supply Product Description: Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution; Isopropyl Alcohol Antiseptic…
Read MoreOriginal Post For Immediate Release: March 28, 2023 Today, the U.S. Food and Drug Administration released a national strategy outlining actions the agency will take immediately to help ensure one of the nation’s most vulnerable populations continue to have access to safe, nutritious infant formula and to increase resiliency of the U.S. infant formula market…
Read MoreOriginal Post Is your medicine cabinet full of expired drugs or medications you no longer use? Your medicine is for you. What’s safe for you might be harmful for someone else. The best way to dispose of your expired, unwanted, or unused medicines is through a drug take back program — or you can do…
Read MoreOriginal Post Summary Company Announcement Date: March 17, 2023 FDA Publish Date: March 17, 2023 Product Type: Food & Beverages Reason for Announcement: Potential Cronobacter sakazakii contamination Company Name: Perrigo Company plc Brand Name: Gerber Good Start Product Description: Powdered Infant formula Company Announcement Dublin, Ireland – March 17, 2023 – Perrigo Company plc is…
Read More